Mizuho Downgrades Life Tech, Thermo Fisher Amid Concerns Over Academic Spending | GenomeWeb

NEW YORK (GenomeWeb News) – Mizuho Securities today downgraded Life Technologies and Thermo Fisher Scientific on concerns about an uncertain academic spending environment.

In a research note, Peter Lawson downgraded both firms to Neutral from Buy. He lowered his price target for Life Tech to $45 from $52 and trimmed the price target for Thermo Fisher to $55 from $65.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.